Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial

M. Sasaki; K. Imaeda; N. Okayama; T. Mizuno; H. Kataoka; T. Kamiya; E. Kubota; N. Ogasawara; Y. Funaki; M. Mizuno; A. Iida; C. Goto; S. Koikeda; K. Kasugai; T. Joh

doi:10.1111/j.1463-1326.2011.01539.x

Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2011.01539.x ◽

2011 ◽

Vol 14 (4) ◽

pp. 379-382 ◽

Cited By ~ 4

Author(s):

M. Sasaki ◽

K. Imaeda ◽

N. Okayama ◽

T. Mizuno ◽

H. Kataoka ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Endothelial function and cardiovascular risk factors in young healthy adult offspring of parents with type 2 diabetes: Effect of vitamin E in a randomised double-blind placebo-controlled trial

Atherosclerosis ◽

10.1016/s0021-9150(00)80952-1 ◽

2000 ◽

Vol 151 (1) ◽

pp. 209

Author(s):

P. McSorley ◽

I. Young ◽

P. Bell ◽

A. Atkinson ◽

C. Ennis ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Vitamin E ◽

Healthy Adult ◽

Controlled Trial ◽

Adult Offspring ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Dapagliflozin’s Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

Diabetes Care ◽

10.2337/dc14-0315 ◽

2015 ◽

Vol 38 (7) ◽

pp. 1218-1227 ◽

Cited By ~ 69

Author(s):

William T. Cefalu ◽

Lawrence A. Leiter ◽

Tjerk W.A. de Bruin ◽

Ingrid Gause-Nilsson ◽

Jennifer Sugg ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

High Risk ◽

Cardiovascular Risk Factors ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Risk Patients

Download Full-text

Effects of Stress Reduction on Cardiovascular Risk Factors in Type 2 Diabetes Patients with Early Kidney Disease – Results of a Randomized Controlled Trial (HEIDIS)

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-0034-1372583 ◽

2014 ◽

Vol 122 (06) ◽

pp. 341-349 ◽

Cited By ~ 20

Author(s):

S. Kopf ◽

D. Oikonomou ◽

M. Hartmann ◽

F. Feier ◽

V. Faude-Lang ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Cardiovascular Risk ◽

Kidney Disease ◽

Cardiovascular Risk Factors ◽

Stress Reduction ◽

Controlled Trial ◽

Randomized Controlled

Download Full-text

Effects of krill oil on endothelial function and other cardiovascular risk factors in participants with type 2 diabetes, a randomized controlled trial

BMJ Open Diabetes Research & Care ◽

10.1136/bmjdrc-2015-000107 ◽

2015 ◽

Vol 3 (1) ◽

pp. e000107 ◽

Cited By ~ 18

Author(s):

Jessika M Lobraico ◽

Lauren C DiLello ◽

Amber D Butler ◽

Marie Elena Cordisco ◽

Joann R Petrini ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Cardiovascular Risk ◽

Endothelial Function ◽

Cardiovascular Risk Factors ◽

Controlled Trial ◽

Krill Oil ◽

Randomized Controlled

Download Full-text

Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over clinical trial

European Journal of Nutrition ◽

10.1007/s00394-018-1642-0 ◽

2018 ◽

Vol 58 (3) ◽

pp. 1237-1245 ◽

Cited By ~ 11

Author(s):

Vladimir Vuksan ◽

Zenith Zheng Xu ◽

Elena Jovanovski ◽

Alexandra L. Jenkins ◽

Uljana Beljan-Zdravkovic ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Cardiovascular Risk ◽

Glycemic Control ◽

Cardiovascular Risk Factors ◽

Panax Quinquefolius ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults

Diabetologia ◽

10.1007/s00125-017-4323-2 ◽

2017 ◽

Vol 60 (11) ◽

pp. 2183-2191 ◽

Cited By ~ 20

Author(s):

Rebecca K. Simmons ◽

Simon J. Griffin ◽

Daniel R. Witte ◽

Knut Borch-Johnsen ◽

Torsten Lauritzen ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Mortality Rate ◽

Cardiovascular Risk Factors ◽

Cardiovascular Events ◽

Controlled Trial ◽

Population Screening

Download Full-text

Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial

Atherosclerosis ◽

10.1016/s0021-9150(02)00372-6 ◽

2003 ◽

Vol 166 (2) ◽

pp. 379-386 ◽

Cited By ~ 131

Author(s):

Mirjam Christ-Crain ◽

Christian Meier ◽

Merih Guglielmetti ◽

Peter R. Huber ◽

Walter Riesen ◽

...

Keyword(s):

Risk Factors ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Controlled Trial ◽

C Reactive Protein ◽

Double Blind ◽

Cross Sectional ◽

Double Blind Placebo ◽

Reactive Protein

Download Full-text

Isoflavones and Clinical Cardiovascular Risk Factors in Obese Postmenopausal Women: A Randomized Double-Blind Placebo-Controlled Trial

Journal of Women s Health ◽

10.1089/jwh.2008.0836 ◽

2008 ◽

Vol 17 (8) ◽

pp. 1363-1369 ◽

Cited By ~ 17

Author(s):

Mylène Aubertin-Leheudre ◽

Christine Lord ◽

Abdelouahed Khalil ◽

Isabelle J. Dionne

Keyword(s):

Risk Factors ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Postmenopausal Women ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: A one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors

Clinical Therapeutics ◽

10.1016/s0149-2918(03)80090-5 ◽

2003 ◽

Vol 25 (2) ◽

pp. 472-484 ◽

Cited By ~ 52

Author(s):

Giuseppe Derosa ◽

Amedeo Mugellini ◽

Leonardina Ciccarelli ◽

Giuseppe Crescenzi ◽

Roberto Fogari

Keyword(s):

Diabetes Mellitus ◽

Risk Factors ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Cardiovascular Risk ◽

Cardiovascular Risk Factors ◽

Metabolic Parameters ◽

Double Blind ◽

One Year

Download Full-text

Abstract #415 Peripheral Arterial Disease and Its Association with Cardiovascular Risk Factors in Type 2 Diabetes

Endocrine Practice ◽

10.1016/s1530-891x(20)47176-9 ◽

2018 ◽

Vol 24 ◽

pp. 103-104

Author(s):

Rohit Kapoor ◽

Shivam Kapoor ◽

Rishabh Kapoor

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Peripheral Arterial Disease ◽

Cardiovascular Risk Factors ◽

Arterial Disease ◽

Peripheral Arterial

Download Full-text